Acurx Pharmaceuticals, Inc.

ALERT: NEW ARTICLE

IDSA Clinical Infectious Diseases; Emergence and spread of Clostridioides difficile Isolates with Reduced Fidaxomicin Susceptibility in an Acute Care Hospital

Read Publication

Continue

Acurx Pharmaceuticals

Acurx Pharmaceuticals is a publicly held, clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention, and Food and Drug Administration.

Learn More